Penbutolol
Back to searchMolecule Structure
Scientific Name
Penbutolol
Description of the Drug
Penbutolol is a beta-adrenergic antagonist used for the management of mild to moderate arterial hypertension, alone or in combination with other antihypertensive agents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01359
http://www.drugbank.ca/drugs/DB01359
Brand Name(s)
Not Available
Company Owner(s)
Auxilium Pharmaceuticals Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
Beta-2 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL41408 | |
PharmGKB | PA164749474 | |
Human Metabolome Database | HMDB0015447 | |
DrugBank | DB01359 | |
PubChem: Thomson Pharma | 15902888 | |
PubChem | 37464 | |
Nikkaji | J22.286K | |
BindingDB | 50470808 | |
EPA CompTox Dashboard | DTXSID8023428 | |
DrugCentral | 2078 | |
ChemicalBook | CB6500517 | |
Guide to Pharmacology | 7263 | |
rxnorm | PENBUTOLOL | PENBUTOLOL SULFATE |
KEGG Ligand | C07416 | |
ChEBI | 7954 | |
ZINC | ZINC000000001898 |